Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
Public ClinicalTrials.gov record NCT01455090. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open-Label, Multiple-Dose, Dose Escalation Study to Evaluate the Pharmacodynamics, Pharmacokinetics, and Safety of Coadministration of BMS-650032, BMS-790052, and BMS-791325 When Administered for 24 or 12 Weeks in Treatment-Naïve Subjects Infected With Hepatitis C Virus Genotype 1
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to estimate the rate of sustained virologic response (SVR) SVR12, where SVR12 is defined as HCV RNA \< LOQ (detectable or undetectable) 12 weeks post-treatment in Genotype 1 \& Genotype 4 treatment naive patients, and Genotype (GT1) infected patients who are prior null responders to pegIFN/ribavirin
Study identification
- NCT ID
- NCT01455090
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 320 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2011 (Actual)
- Primary completion
- Mar 31, 2014 (Actual)
- Completion
- Jul 31, 2015 (Actual)
- Last update posted
- Apr 27, 2017
2011 – 2015
United States locations
- U.S. sites
- 26
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Kirklin Clinic | Birmingham | Alabama | 35294 | — |
| Southern California Research Center | Coronado | California | 92118 | — |
| Peter J Ruane Md Inc | Los Angeles | California | 90036 | — |
| Va Greater Los Angeles Healthcare System | Los Angeles | California | 90073 | — |
| Research And Education, Inc. | San Diego | California | 92105 | — |
| Precision Research Institute, Llc | San Diego | California | 92114 | — |
| Medical Associates Research Group | San Diego | California | 92123 | — |
| University Of Colorado Denver And Hospital | Aurora | Colorado | 80045 | — |
| Medstar Georgetown University Hospital | Washington D.C. | District of Columbia | 20007 | — |
| Orlando Immunology Center | Orlando | Florida | 32803 | — |
| Miami Research Associates | South Miami | Florida | 33143 | — |
| Atlanta Gastroenterology Associates, Llc | Atlanta | Georgia | 30308 | — |
| Mercy Medical Center, Inc. | Baltimore | Maryland | 21202 | — |
| Johns Hopkins University | Lutherville | Maryland | 21093 | — |
| Id Care | Hillsborough | New Jersey | 08844 | — |
| Southwest Care Center | Santa Fe | New Mexico | 87505 | — |
| James J Peters Vamc | The Bronx | New York | 10468 | — |
| Options Health Research, Llc | Tulsa | Oklahoma | 74104 | — |
| Healthcare Research Consultants | Tulsa | Oklahoma | 74135 | — |
| Texas Clinical Research Institute | Arlington | Texas | 76012 | — |
| Research Specialists Of Texas | Houston | Texas | 77030 | — |
| Alamo Medical Research | San Antonio | Texas | 78215 | — |
| Lifetree Clinical Research | Salt Lake City | Utah | 84106 | — |
| Metropolitan Research | Fairfax | Virginia | 22031 | — |
| Inova Fairfax Hospital | Falls Church | Virginia | 22042 | — |
| Dean Clinic | Madison | Wisconsin | 53715 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01455090, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 27, 2017 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01455090 live on ClinicalTrials.gov.